Revenue | ₹2.54Cr |
Net Profits | ₹-2.08Cr |
Net Profit Margins | -81.89% |
Parmax Pharma Ltd’s revenue fell -72.95% since last year same period to ₹2.54Cr in the Q2 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 30.26% jump in its revenue since last 3-months.
Parmax Pharma Ltd’s net profit fell -845.45% since last year same period to ₹-2.08Cr in the Q2 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated -173.68% fall in its net profits since last 3-months.
Parmax Pharma Ltd’s net profit margin fell -3395.2% since last year same period to -81.89% in the Q2 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated -110.11% fall in its net profit margins since last 3-months.
The revenue for Parmax Pharma Ltd in the Q2 results 2025 was ₹2.54Cr.
The net profit for Parmax Pharma Ltd in the Q2 results 2025 was ₹-2.08Cr.
The net profit margin for Parmax Pharma Ltd in the Q2 results 2025 was -81.89%.
The revenue for Parmax Pharma Ltd in the Q2 results 2024 was ₹9.39Cr.
The net profit for Parmax Pharma Ltd in the Q2 results 2024 was ₹0.22Cr.
The net profit margin for Parmax Pharma Ltd in the Q2 results 2024 was -2.34%.